Compounding Pharmacy Supplies Medication for Study Using Edetate Disodium Therapy

Miami, FL, April 27, 2016 --(PR.com)-- Following the generally positive outcome of the National Institutes of Health-funded Trial to Assess Chelation Therapy (TACT)[1] study completed in 2012, it was decided that further research was warranted to test the safety and effectiveness of Chelation therapy as a treatment option for individuals with coronary artery disease (CAD) and prior myocardial infarction (MI).

After their participation in the 2012 TACT study, Universal Arts Compounding Pharmacy was once again chosen to supply the necessary medications for the subsequent Enhanced Vasculotoxic Metal Excretion in Post-MI Patients after Edetate Disodium Therapy study[2]. The methods used by the study, including the edetate disodium-based infusion provided by the pharmacy, was shown to increase patient urinary excretion of toxic metals such as lead and cadmium. After the edetate disodium treatment, urinary metal excretion of these toxic metals increased by 60%. The study concluded that edetate disodium increased urinary excretion of toxic metals, namely lead and cadmium, which have established epidemiologic evidence linking them to coronary and vascular events.

About Universal Arts Compounding Pharmacy: Universal Arts Compounding Pharmacy is the first PCAB (Pharmacy Compounding Accreditation Board) accredited compounding pharmacy in Florida, and among the first ten in the nation to earn the seal. We have earned a special license from The Florida State Board of Pharmacy to compound sterile solutions, as well as non-sterile solutions in order to effectively and safely meet patient needs.

[1] Bauchner H, Fontanarosa PB, Golub RM. Evaluation of the Trial to Assess Chelation Therapy (TACT): The Scientific Process, Peer Review, and Editorial Scrutiny. JAMA.2013;309(12):1291-1292. doi:10.1001/jama.2013.2761.

[2] Arenas I, Navas-Acien A, Lamas G. ENHANCED VASCULOTOXIC METAL EXCRETION IN POST-MYOCARDIAL INFARCTION PATIENTS RECEIVING EDETATE DISODIUM-BASED INFUSION. J Am Coll Cardiol. 2016;67(13_S):2125. doi:10.1016/S0735-1097(16)32126-X.

For more information on Universal Arts Compounding Pharmacy, please visit:

http://www.uaprx.com